Side Effect Management
Weekly Fosaprepitant Betters Quality of Life During Chemoradiotherapy
August 2nd 2023Patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy reported higher quality of life and were less likely to experience vomiting when receiving fosaprepitant every week as opposed to every three weeks.